PMVP
PMV Pharmaceuticals, Inc.NASDAQHealthcare$1.34+0.75%ClosedMarket Cap: $71.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.66
P/S
0.00
EV/EBITDA
-0.39
DCF Value
$0.65
FCF Yield
-106.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-59.1%
ROA
-66.7%
ROIC
-79.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-19.2M | $-18.0M | $-0.34 | — |
| FY 2025 | $0.00 | -Infinity% | $-86.2M | $-77.7M | $-1.48 | — |
| Q3 2025 | $0.00 | -Infinity% | $-22.5M | $-21.1M | $-0.40 | — |
| Q2 2025 | $0.00 | -Infinity% | $-22.9M | $-21.2M | $-0.41 | — |
| Q1 2025 | $0.00 | NaN% | $-21.6M | $-17.4M | $-0.34 | — |
| Q4 2024 | $0.00 | NaN% | $-25.2M | $-23.0M | $0.37 | — |
| FY 2024 | $0.00 | -Infinity% | $-85.4M | $-58.7M | $-1.14 | — |
| Q3 2024 | $0.00 | NaN% | $-21.9M | $-19.2M | $-0.37 | — |
| Q2 2024 | $0.00 | -Infinity% | $-20.2M | $-1.2M | $-0.02 | — |
| Q1 2024 | $0.00 | -Infinity% | $-18.2M | $-15.3M | $-0.30 | — |
| Q4 2023 | $0.00 | -Infinity% | $-18.9M | $-15.8M | $-0.31 | — |
| FY 2023 | $0.00 | -Infinity% | $-80.1M | $-69.0M | $-1.44 | — |